Hepatitis B virus treatment: Management of antiviral drug resistance-Reference-Cited by-同舟云学术

Hepatitis B virus treatment: Management of antiviral drug resistance

Published:2013-02 Issue:1 Volume:2 Page:24-28
ISSN:2046-2484
Container-title:Clinical Liver Disease
language:en
Short-container-title:Clinical Liver Disease

Author:

Tana Michele M.,Ghany Marc G.

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cld.162/fullpdf

Reference18 articles.

1. Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management;Lok;Hepatology,2007

2. Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5 years of therapy;Tenney;Hepatology,2009

3. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study;Marcellin;Lancet;

4. Lamivudine for patients with chronic hepatitis B and advanced liver disease;Liaw;N Engl J Med,2004

5. Long-term safety of lamivudine treatment in patients with chronic hepatitis B;Lok;Gastroenterology,2003

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acquired knowledge and identified gaps in resistance and human health risk;Antimicrobial Resistance in Wastewater and Human Health;2023

2. Life cycle synchronization is a viral drug resistance mechanism;PLOS Computational Biology;2018-02-15

3. Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance;Proceedings of the National Academy of Sciences;2015-05-18

4. The Problem of Microbial Drug Resistance;Novel Antimicrobial Agents and Strategies;2014-11-14

5. Multiplex SNP detection in multiple codons for accurate drug therapy;Chem. Commun.;2014